HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Detection of HTLV-I pX gene by polymerase chain reaction using newly designed primers.

Abstract
Newly designed oligonucleotide primers, KI-7 and KI-8 for the human T cell lymphotropic virus type I (HTLV-I) pX gene were synthesized using an automated DNA synthesizer. Previously known HTLV-I-infected cell lines, MT-1 and MT-2, were used as positive controls and HTLV-I-uninfected cell lines, Molt-4, SBC-3, ABC-1, and EBC-1, as negative controls. Peripheral blood mononuclear cells from 17 patients with anti-HTLV-I antibody and 10 healthy individuals without anti-HTLV-I antibody were studied by polymerase chain reaction (PCR) with KI-7 and KI-8. All DNA samples from HTLV-I-infected cell lines and 17 patients with anti-HTLV-I antibodies showed positive signals of the HTLV-I pX gene. None of the DNA samples from HTLV-I-uninfected cell lines or 10 healthy individuals showed positive signals. When serially diluted DNA of MT-2 cells were amplified by 35 cycles of PCR, the detection limit of the pX gene by using the primer pairs was DNA from about 1.5 MT-2 cells. Specificity and detectable capacity of primer pairs, KI-7 and KI-8 were confirmed to be enough to use for the diagnosis of HTLV-I infection.
AuthorsK Imajo, K Shinagawa, S Tada, T Tsubota, I Kimura
JournalActa medica Okayama (Acta Med Okayama) Vol. 47 Issue 6 Pg. 355-61 (Dec 1993) ISSN: 0386-300X [Print] Japan
PMID8128908 (Publication Type: Journal Article)
Chemical References
  • DNA, Viral
  • HTLV-I Antibodies
  • Oligonucleotide Probes
Topics
  • Base Sequence
  • Blotting, Southern
  • Cell Line
  • DNA, Viral (analysis)
  • Genes, pX
  • HTLV-I Antibodies (analysis)
  • Human T-lymphotropic virus 1 (genetics)
  • Humans
  • Molecular Sequence Data
  • Oligonucleotide Probes (genetics)
  • Polymerase Chain Reaction (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: